United States · Platforms & data · MarketBeat

Chardan Capital Reaffirms "Buy" Rating for Agenus (NASDAQ:AGEN)

Published by MarketBeat · United States 1 h ago

Chardan Capital reaffirmed a "buy" rating and set a $40.00 target price on shares of Agenus in a report on Thursday.

Read the full article on MarketBeat Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketbeat.com)

Also worth reading

The Motley Fool

Investing in Artificial Intelligence (AI) Stocks Can be Risky, but This Might be a Great Way to Do It

Fusion Fuel Green deal cuts QIND’s Al Shola Gas payments due to $7M

Markets are pricing in long-term AI winners. This veteran investor says history proves customers win more than innovators.

Best Tech Stocks Right Now

Cantor Fitzgerald reiterates Texas Instruments stock neutral rating

Ernexa Therapeutics Highlights ERNA-101’s Path Toward the Clinic and Differentiated Cell Therapy Platform in New “What This Means” Segment